1. Home
  2. VIR vs RCAT Comparison

VIR vs RCAT Comparison

Compare VIR & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$7.61

Market Cap

843.1M

Sector

Health Care

ML Signal

HOLD

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$15.77

Market Cap

957.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
RCAT
Founded
2016
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
843.1M
957.4M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
VIR
RCAT
Price
$7.61
$15.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$28.63
$14.50
AVG Volume (30 Days)
1.7M
14.6M
Earning Date
02-25-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,860,000.00
$7,443,942.00
Revenue This Year
N/A
$396.50
Revenue Next Year
N/A
$296.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$4.58
52 Week High
$11.39
$18.02

Technical Indicators

Market Signals
Indicator
VIR
RCAT
Relative Strength Index (RSI) 67.87 71.65
Support Level $5.80 $13.08
Resistance Level $6.90 $18.02
Average True Range (ATR) 0.47 1.62
MACD 0.16 0.51
Stochastic Oscillator 92.50 76.81

Price Performance

Historical Comparison
VIR
RCAT

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

Share on Social Networks: